EMD 72000

· Merck KGaA

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EMD 72000, covering 2014-02-19 to 2017-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer [Phase 2]